Rx Act Nasal Original

Rx Act Nasal Original

Rx Act Nasal Original Recall

Get an alert when a recall is issued.

Questions & Answers

Side Effects & Adverse Reactions

There is currently no warning information available for this product. We apologize for any inconvenience.

Legal Issues

There is currently no legal information available for this drug.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

Choline C 11 Injection is indicated for positron emission tomography (PET) imaging of patients with suspected prostate cancer recurrence and non-informative bone scintigraphy, computerized tomography (CT) or magnetic resonance imaging (MRI). In these patients, 11 C-choline PET imaging may help identify potential sites of prostate cancer recurrence for subsequent histologic confirmation. Suspected prostate recurrence is based upon elevated blood prostate specific antigen (PSA) levels following initial therapy. In clinical studies, images were produced with PET/CT coregistration.

Limitation of Use: 11 C-choline PET imaging is not a replacement for histologic verification of recurrent prostate cancer.

History

There is currently no drug history available for this drug.

Other Information

11.1       Chemical Characteristics

Choline C 11 Injection is a positron emitting radiopharmaceutical that is used for diagnostic purposes in conjunction with PET imaging.  The active ingredient, 11C-choline, has the molecular formula of C411CH14 NOCl with a molecular weight of 138.63 g and has the following chemical structure:

Choline C 11 chemical structure

Choline C 11 Injection is provided as a ready to use sterile, pyrogen-free, clear and colorless solution.  Each milliliter contains 148 – 1,225 MBq (4 – 33.1 mCi) of 11C-choline at EOS calibration time in aqueous 0.9% sodium chloride solution.  The pH of the solution is between 4.5 and 7.5.  

11.2       Physical Characteristics

Carbon 11 is a cyclotron-produced radionuclide that decays to Boron 11 by positron emission and has a physical half life of 20.4 minutes (Table 2).

Table 2: Principal Radiation Emission Data for 11C
 Radiation/Emission  % Per Disintegration  Energy
 Positron (β+)
 99.76  960.2 keV (Max.)
 Gamma (±)*
 199.5  511 keV

*Produced by positron annihilation

The specific gamma ray constant (point source air kerma coefficient) for 11C-choline is 5.8 R/mCi-hr at 1 cm.  Selected coefficients of attenuation are listed in Table 3 as a function of lead shield thickness.  For example, the use of 39 mm thickness of lead will attenuate the external radiation by a factor of about 1,000. 

Table 3: Radiation Attenuation of 511 keV Photons by lead (Pb) shielding
 Shield Thickness (Pb) mm  Coefficient of Attenuation
 4  0.5
 8  0.25
 13  0.1
 26  0.01
 39   0.001
 52  0.0001

Table 4 lists fractions remaining at selected time intervals from the calibration time.  This information may be used to correct for physical decay of the radionuclide.

Table 4: Physical Decay Chart for 11
 Minutes  Fraction Remaining
 0*  1.000
 5  0.844 
 10  0.712 
 15  0.600 
 20  0.507 
 25  0.427 
 30  0.360 

*Calibration time

Rx Act Nasal Original Manufacturers


  • H E B
    Rx Act Nasal Original (Oxymetazoline Hydrochloride) Spray [H E B]

Login To Your Free Account